SWITCHING FROM AN INTENSIFIED REGIMEN OF INFLIXIMAB TO A SUBCUTANEOUS STANDARD DOSE IN ADULTS WITH INFLAMMATORY BOWEL DISEASE: OUR EXPERIENCE IN A TERTIARY HOSPITAL
Irene Chivato Martín-Falquina 1
Blanca Vicente González 2
Lara Arias-García 2
Natalia Revilla Cuesta 2
ROSA MARIA SAIZ CHUMILLAS 2
Beatriz Sicilia Aladrén 3
1 Hospital Universitario Burgos, Burgos, Spain
2 Hospital Universitario de Burgos, Burgos, Spain
3 H Universitario de Burgos, Burgos, Spain
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]